A287410 Stock Overview
Jeisys Medical Inc. designs, develops, and manufactures medical device for plastic surgeons, dermatologist, physicians, and healthcare professionals in South Korea and internationally.
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 4/6 |
Past Performance | 2/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
Jeisys Medical Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₩9,370.00 |
52 Week High | ₩14,500.00 |
52 Week Low | ₩7,390.00 |
Beta | 0.45 |
1 Month Change | 17.57% |
3 Month Change | 7.45% |
1 Year Change | 7.70% |
3 Year Change | 104.14% |
5 Year Change | n/a |
Change since IPO | 120.47% |
Recent News & Updates
Shareholder Returns
A287410 | KR Medical Equipment | KR Market | |
---|---|---|---|
7D | -20.5% | 3.8% | -0.4% |
1Y | 7.7% | 30.6% | 4.5% |
Return vs Industry: A287410 underperformed the KR Medical Equipment industry which returned 33.4% over the past year.
Return vs Market: A287410 matched the KR Market which returned 7.1% over the past year.
Price Volatility
A287410 volatility | |
---|---|
A287410 Average Weekly Movement | 9.3% |
Medical Equipment Industry Average Movement | 6.2% |
Market Average Movement | 5.2% |
10% most volatile stocks in KR Market | 11.8% |
10% least volatile stocks in KR Market | 2.4% |
Stable Share Price: A287410's share price has been volatile over the past 3 months.
Volatility Over Time: A287410's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of KR stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2001 | 231 | n/a | www.jeisys.com/2016 |
Jeisys Medical Inc. designs, develops, and manufactures medical device for plastic surgeons, dermatologist, physicians, and healthcare professionals in South Korea and internationally. The company offers products for treatment areas, such as skin rejuvenation, lifting/tightening, pigmentation treatments, fat reduction, acne, tattoo removal, and scars and striae distensae under the ULTRAcel Q+ system, Cellec V system, LIPOcel, AcGen, TRI-BEAM Premium, Edge ONE, SmoothCool, and ULTRAcel brands. It provides its products through a network of distributors.
Jeisys Medical Inc. Fundamentals Summary
A287410 fundamental statistics | |
---|---|
Market cap | ₩706.79b |
Earnings (TTM) | ₩24.80b |
Revenue (TTM) | ₩143.03b |
28.5x
P/E Ratio4.9x
P/S RatioIs A287410 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
A287410 income statement (TTM) | |
---|---|
Revenue | ₩143.03b |
Cost of Revenue | ₩44.14b |
Gross Profit | ₩98.89b |
Other Expenses | ₩74.09b |
Earnings | ₩24.80b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | 328.78 |
Gross Margin | 69.14% |
Net Profit Margin | 17.34% |
Debt/Equity Ratio | 23.9% |
How did A287410 perform over the long term?
See historical performance and comparison